Valeriana + Pustyrnik Forte mercana (Tablets) Instructions for Use
Marketing Authorization Holder
Mercana Service, LLC (Russia)
Manufactured By
V-MIN+, LLC (Russia)
Dosage Form
 |
Valeriana + Pustyrnik Forte mercana | Lozenges |
Dosage Form, Packaging, and Product Composition
| Lozenges weighing 0.5 g | 1 tab. |
| Biologically active components, not less than | |
| Flavonoids | 1 mg |
| Valeric acid | 0.3 mg |
Composition valerian extracts, motherwort extracts, citric acid, glutamic acid, sorbitol, calcium stearate.
Tablets.
Properties
Dietary supplement.
Motherwort herb has a sedative, hypotensive, negative chronotropic, and cardiotonic effect. The action is due to the properties of biologically active substances contained in the plant (including glycosides, alkaloids, flavonoids, saponins).
Valerian causes a moderately pronounced sedative effect. The action is due to the content of essential oil, most of which is an ester of borneol and isovaleric acid. Valepotriates and alkaloids – valerine and chotenine – also have sedative properties. Valerian facilitates the onset of natural sleep. The sedative effect develops slowly but is quite stable. Valeric acid and valepotriates have a weak antispasmodic effect. In addition, the complex of biologically active substances of valerian officinalis has a choleretic effect, enhances the secretory activity of the gastrointestinal mucosa, slows the heart rate, and dilates the coronary vessels. The regulation of cardiac activity is mediated through neuroregulatory mechanisms and a direct influence on the automation and conduction system of the heart.
When motherwort herb and valerian are combined, the sedative effect and the effect on the cardiovascular system are enhanced.
Scope of Application
Neurotic and astheno-neurotic disorders accompanied by sleep disturbances; neurasthenia, neuroses, and vegetative-vascular dystonia. Vegetative neuroses in the preclimacteric period, accompanied by increased blood pressure, tachycardia, and cardialgia. Increased excitability and tachycardia in hyperthyroidism.
ICD codes
| ICD-10 code | Indication |
| E05 | Thyrotoxicosis [hyperthyroidism] |
| F45.3 | Somatoform dysfunction of the autonomic nervous system |
| F48.0 | Neurasthenia |
| F48.9 | Unspecified neurotic disorder |
| F51.2 | Nonorganic disorders of the sleep-wake schedule |
| N95.1 | Menopausal and other perimenopausal disorders |
| N95.3 | States associated with artificial menopause |
| R00.0 | Tachycardia, unspecified (including nodal (sinus) NOS) |
| R03.0 | Elevated blood-pressure reading without diagnosis of hypertension |
| R07.2 | Pain in the heart region |
| R45.1 | Restlessness and agitation |
| ICD-11 code | Indication |
| 5A02.Z | Thyrotoxicosis, unspecified |
| 6A8Z | Affective disorders, unspecified |
| 6B6Z | Dissociative disorders, unspecified |
| 6C20.Z | Bodily distress disorder, unspecified |
| 7B2Z | Sleep-wake cycle disorders, unspecified |
| GA30.00 | Menopausal or climacteric states in women |
| GA30.3 | States associated with artificial menopause |
| MB24.F | Restlessness |
| MC80.0Z | Elevated blood pressure without diagnosis of hypertension, unspecified |
| MC81.Z | Abnormalities of heart rhythm, unspecified |
| MC86 | Precordial pain |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Take orally. The dose is determined individually, depending on the product used.
Side effects
In some cases allergic reactions.
Contraindications
Hypersensitivity to the components of the product used.
Special instructions
This is not a medicinal product.
Before using the product, consult a doctor.
Do not exceed the recommended dose of the product used.
In children, use only dietary supplements intended for the corresponding age group.
Drug Interactions
When used concomitantly with drugs that have a depressant effect on the central nervous system, their effect may be enhanced.
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer![Valeriana + Pustyrnik Forte mercana [Tablets] 1](https://www.medixlife.com/wp-content/uploads/Medixlife_favi_512.png "Valeriana + Pustyrnik Forte mercana [Tablets] 2")